PLASTIVALOIRE(EPA:PVL) stock Fundamental Analysis

Fundamental Rating

Taking everything into account, PVL scores 2 out of 10 in our fundamental rating. PVL was compared to 61 industry peers in the Chemicals industry. PVL may be in some trouble as it scores bad on both profitability and health. PVL is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year PVL has reported negative net income.

In the past year PVL had a positive cash flow from operations.

In the past 5 years PVL reported 4 times negative net income.

PVL had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of PVL (-6.28%) is worse than 65.08% of its industry peers.

PVL has a worse Return On Equity (-23.23%) than 73.02% of its industry peers.

Looking at the Return On Invested Capital, with a value of 1.40%, PVL is in line with its industry, outperforming 47.62% of the companies in the same industry.

PVL had an Average Return On Invested Capital over the past 3 years of 2.18%. This is below the industry average of 6.72%.

		Industry Rank	Sector Rank
ROA	-6.28%
ROE	-23.23%
ROIC	1.4%

ROA(3y)-3.76%

ROA(5y)-2.43%

ROE(3y)-13.19%

ROE(5y)-8.49%

ROIC(3y)2.18%

ROIC(5y)N/A

1.3 Margins

PVL has a Operating Margin of 1.26%. This is comparable to the rest of the industry: PVL outperforms 47.62% of its industry peers.

In the last couple of years the Operating Margin of PVL has declined.

PVL's Gross Margin of 48.03% is fine compared to the rest of the industry. PVL outperforms 71.43% of its industry peers.

In the last couple of years the Gross Margin of PVL has grown nicely.

		Industry Rank	Sector Rank
OM	1.26%
PM (TTM)	N/A
GM	48.03%

OM growth 3Y-24.59%

OM growth 5Y-25.32%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.37%

GM growth 5Y2.85%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

PVL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.

PVL has about the same amout of shares outstanding than it did 1 year ago.

The number of shares outstanding for PVL remains at a similar level compared to 5 years ago.

Compared to 1 year ago, PVL has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.62, we must say that PVL is in the distress zone and has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 1.62, PVL is doing worse than 65.08% of the companies in the same industry.

A Debt/Equity ratio of 1.21 is on the high side and indicates that PVL has dependencies on debt financing.

The Debt to Equity ratio of PVL (1.21) is worse than 80.95% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.21
Debt/FCF	N/A
Altman-Z	1.62

ROIC/WACC0.36

WACC3.92%

2.3 Liquidity

A Current Ratio of 1.39 indicates that PVL should not have too much problems paying its short term obligations.

Looking at the Current ratio, with a value of 1.39, PVL is doing worse than 66.67% of the companies in the same industry.

A Quick Ratio of 1.21 indicates that PVL should not have too much problems paying its short term obligations.

PVL's Quick ratio of 1.21 is fine compared to the rest of the industry. PVL outperforms 63.49% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.39
Quick Ratio	1.21

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

PVL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -175.68%.

The Revenue has decreased by -7.04% in the past year.

The Revenue has been decreasing by -0.69% on average over the past years.

EPS 1Y (TTM)-175.68%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-19400%

Revenue 1Y (TTM)-7.04%

Revenue growth 3Y1.28%

Revenue growth 5Y-0.69%

Sales Q2Q%-11.27%

3.2 Future

PVL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 144.95% yearly.

The Revenue is expected to decrease by -2.84% on average over the next years.

EPS Next Y-1300%

EPS Next 2Y144.95%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-7.43%

Revenue Next 2Y-2.84%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PVL. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PVL. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PVL indicates a rather cheap valuation: PVL is cheaper than 95.24% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	4.85

4.3 Compensation for Growth

A more expensive valuation may be justified as PVL's earnings are expected to grow with 144.95% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y144.95%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

PVL does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

PLASTIVALOIRE

EPA:PVL (3/7/2025, 7:00:00 PM)

1.465

+0.03 (+1.74%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)02-17 2025-02-17

Earnings (Next)05-15 2025-05-15

Inst Owners1.11%

Inst Owner ChangeN/A

Ins Owners54.69%

Ins Owner ChangeN/A

Market Cap32.42M

Analysts47.5

Price Target1.48 (1.02%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-488.89%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-11.68%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.05
P/FCF	N/A
P/OCF	0.9
P/B	0.17
P/tB	0.26
EV/EBITDA	4.85

EPS(TTM)-2.04

EYN/A

EPS(NY)-1.41

Fwd EYN/A

FCF(TTM)-0.09

FCFYN/A

OCF(TTM)1.63

OCFY111.39%

SpS31.79

BVpS8.77

TBVpS5.58

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-6.28%
ROE	-23.23%
ROCE	2.07%
ROIC	1.4%
ROICexc	1.4%
ROICexgc	1.66%
OM	1.26%
PM (TTM)	N/A
GM	48.03%
FCFM	N/A

ROA(3y)-3.76%

ROA(5y)-2.43%

ROE(3y)-13.19%

ROE(5y)-8.49%

ROIC(3y)2.18%

ROIC(5y)N/A

ROICexc(3y)2.53%

ROICexc(5y)N/A

ROICexgc(3y)3.11%

ROICexgc(5y)N/A

ROCE(3y)3.17%

ROCE(5y)N/A

ROICexcg growth 3Y-20.84%

ROICexcg growth 5Y-21.45%

ROICexc growth 3Y-19.92%

ROICexc growth 5Y-21.2%

OM growth 3Y-24.59%

OM growth 5Y-25.32%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.37%

GM growth 5Y2.85%

F-Score5

Asset Turnover0.98

Health

		Industry Rank	Sector Rank
Debt/Equity	1.21
Debt/FCF	N/A
Debt/EBITDA	4.41
Cap/Depr	85.85%
Cap/Sales	5.42%
Interest Coverage	0.89
Cash Conversion	67.81%
Profit Quality	N/A
Current Ratio	1.39
Quick Ratio	1.21
Altman-Z	1.62

F-Score5

WACC3.92%

ROIC/WACC0.36

Cap/Depr(3y)60.25%

Cap/Depr(5y)56.65%

Cap/Sales(3y)3.98%

Cap/Sales(5y)3.96%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-175.68%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-19400%

EPS Next Y-1300%

EPS Next 2Y144.95%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-7.04%

Revenue growth 3Y1.28%

Revenue growth 5Y-0.69%

Sales Q2Q%-11.27%

Revenue Next Year-7.43%

Revenue Next 2Y-2.84%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-70.23%

EBIT growth 3Y-23.63%

EBIT growth 5Y-25.84%

EBIT Next Year815.49%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-107.99%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-32.76%

OCF growth 3Y-26.28%

OCF growth 5Y-7.25%

PLASTIVALOIRE (PVL.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens